Low Carbon Development Strategy on Land Use Sector in Ciliwung Middle-stream Watershed

The second (2nd) and third (3rd) segment of Ciliwung middle-stream watershed land use have changed drastically over the past two decades. The second (2nd) and third (3rd) segment of Ciliwung middle-stream watershed land use have changed drastically over the past two decades. This paper analyses the land use change from 1989-2012 and its impact on decreasing carbon stock or increasing CO2 eq emission, as well as to establish projected Reference Level (RL) to 2020. Best RL projection was used to establish the Low Carbon Development Strategy (LCDS) in both segments. The land use changing from 1989-2012 indicated a reduction of green space area by 2,575.57 ha whereas the non-green space area increased by 2,575.57 ha. These changes decreases the carbon stock by 26,900 ton C and released CO eq emission by about 98,723 ton CO2eq. Population growth, demand on land and land constraints were found to be the driving factors of land use changes in this area. Reference Level 2020 was established based on business as usual (BAU) and forward looking (FL) scenarios. The projection showed that FL was the best scenario which estimated carbon storage at 217,610 ton C in 2020. Low carbon development strategy directed to the area of green space added up to 20% carbon storage through the implementation of the strategy based on green space and non-green space which covered the areas from protection, supervision, extension or awareness and law enforcement

May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

Aims Raised blood pressure (BP) is the biggest contributor to mortality and disease burden worldwide and fewer than half of those with hypertension are aware of it. May Measurement Month (MMM) is a global campaign set up in 2017, to raise awareness of high BP and as a pragmatic solution to a lack of formal screening worldwide. The 2018 campaign was expanded, aiming to include more participants and countries. Methods and results Eighty-nine countries participated in MMM 2018. Volunteers (≥18 years) were recruited through opportunistic sampling at a variety of screening sites. Each participant had three BP measurements and completed a questionnaire on demographic, lifestyle, and environmental factors. Hypertension was defined as a systolic BP ≥140 mmHg or diastolic BP ≥90 mmHg, or taking antihypertensive medication. In total, 74.9% of screenees provided three BP readings. Multiple imputation using chained equations was used to impute missing readings. 1 504 963 individuals (mean age 45.3 years; 52.4% female) were screened. After multiple imputation, 502 079 (33.4%) individuals had hypertension, of whom 59.5% were aware of their diagnosis and 55.3% were taking antihypertensive medication. Of those on medication, 60.0% were controlled and of all hypertensives, 33.2% were controlled. We detected 224 285 individuals with untreated hypertension and 111 214 individuals with inadequately treated (systolic BP ≥ 140 mmHg or diastolic BP ≥ 90 mmHg) hypertension. Conclusion May Measurement Month expanded significantly compared with 2017, including more participants in more countries. The campaign identified over 335 000 adults with untreated or inadequately treated hypertension. In the absence of systematic screening programmes, MMM was effective at raising awareness at least among these individuals at risk